Showing results (931-940 of 1,984) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|December 2, 2014
Prediagnostic presentations of Parkinson's disease in primary care: a case-control studyAnette Schrag, Laura Horsfall, Kate Walters, et al.
The Lancet. Neurology|December 3, 2014
Clinical symptoms, diagnosis, and treatment of neurocysticercosisHector H Garcia, Theodore E Nash, Oscar H Del Brutto
The Lancet. Neurology|July 26, 2013
Blast-related traumatic brain injuryJeffrey V Rosenfeld, Alexander C McFarlane, Peter Bragge, et al.
The Lancet. Neurology|February 8, 2018
Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional studyPhilip S J Weston, Jennifer M Nicholas, Susie M D Henley, et al.
The Lancet. Neurology|January 15, 2018
The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy studyMark A Rodrigues, Neshika Samarasekera, Christine Lerpiniere, et al.
The Lancet. Neurology|December 26, 2017
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective studyMassimo Filippi, Paolo Preziosa, Alessandro Meani, et al.
The Lancet. Neurology|December 22, 2017
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association studyRita Guerreiro, Owen A Ross, Celia Kun-Rodrigues, et al.
The Lancet. Neurology|March 4, 2018
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational studyBruno Dubois, Stephane Epelbaum, Francis Nyasse, et al.
The Lancet. Neurology|August 15, 2015
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling studyMike A Nalls, Cory Y McLean, Jacqueline Rick, et al.
The Lancet. Neurology|May 5, 2018
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyCyril Pottier, Xiaolai Zhou, Ralph B Perkerson, et al.
Pageof 199